What's breaking now, across thousands of outlets.
(RTTNews) - AbbVie (ABBV) and Genmab (GMAB) reported positive topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating epcoritamab plus R-CHOP in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Being fit as a teenager may help protect against depression in adulthood, a new study suggests.
Medical technology developer SiBionics presented continuous glucose monitoring systems and automated insulin delivery solutions at the European Association for the Study of Diabetes 2026 conference
Galderma celebrates the 30th anniversary of Restylane, its pioneering range of hyaluronic acid (HA) injectables that established the category as the first to market1 With three decades of innovation…
Grade 10 pupil wounded in Wedela mass shooting on 26 September reportedly waiting for surgery after hospital demanded R28000.
Mumbai: Zydus Lifesciences Limited , in partnership with MSN Laboratories Private Limited, announced on October 5, 2026, the launch of Riociguat Tablets in the United States.
Toronto, ON, Oct. 06, 2026 (GLOBE NEWSWIRE) — Nox Peptides today announced an expanded focus on providing information and access to research peptide supplies for Canadian laboratories, academic…
